rhGH treatment in corticosteroid-treated patients

Hormone Research

Volumn 68, Issue 1, 2007, Pages 38-45

  Simon, Dominique ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

Author keywords

Body composition; Chronic diseases; Glucocorticoids; Growth hormone treatment; Growth retardation

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; HUMAN GROWTH HORMONE; PREDNISONE;

BODY COMPOSITION; BODY HEIGHT; CLINICAL TRIAL; CROHN DISEASE; CUSHINGOID SYNDROME; DISEASE COURSE; DRUG SAFETY; FOLLOW UP; FRACTURE; GLUCOSE TOLERANCE; GROWTH DISORDER; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; JUVENILE RHEUMATOID ARTHRITIS; METABOLIC DISORDER; MONITORING; NEPHROTIC SYNDROME; OSTEOPOROSIS; PRIORITY JOURNAL; SHORT SURVEY;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; METABOLIC DISEASES; RECOMBINANT PROTEINS;

EID: 34249944062     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100873     Document Type: Short Survey

References (57)

1. Motil KJ, Grand RJ, Davis-Kraft L, Ferlic LL, Smith EO: Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993;105:681-691.
2. Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM: Growth and clinical course of children with Crohn's disease. Gut 1993;34:939-943.
3. Ansell BM, Bywaters EGL: Growth in Still's disease. Ann Rheum Dis 1956;15:295-319.
4. Falcini F, Tacetti G, Trapani S, Tafi L, Volpi M: Growth retardation in juvenile chronic arthritis patients treated with steroids. Clin Exp Rheumatol 1991;9(suppl 6):37-40.
5. Simon D, Fernando C, Czernichow P, Prieur AM: Linear growth and final height in patients with systemic juvenile chronic arthritis treated with long-term glucocorticoids. J Rheumatol 2002;29:1296-300.
6. Rees L, Greene S, Adlard P, et al: Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child 1988;63:484-490.
7. Donatti T, Koch V, Fujimura M, et al: Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients. Pediatr Nephrol 2003;18:789-795.
8. Emma F, Sesto A, Rizzoni G: Long-term linear growth of children with severe steroid-responsive nephrotic syndrome. Pediatr Nephrol 2003;18:783-788.
9. McEnery P, Gonzalez L, Martin L, West C: Growth and development of children with renal transplants. J Pediatr 1973;83:806-814.
10. Broyer M, Guest G, Gagnadoux M-F: Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation. J Pediatr 1992;120:721-725.
11. Hokken Koelega A, van Zaal M, de Ridder M, Wolff E, De Jong M, Donckerwolcke R, Muinck Keizer-Shrama S, Drop S: Growth after renal transplantation in prepubertal children: impact of various treatment modalities. Pediatr Res 1994;35:367-371.
12. Hokken Koelega A, van Zaal M, van Bergen W, de Ridder M, Stijnen T, Wolff E, De Jong M, Donckerwolcke R, de Muinck Keizer-Shrama S, Drop S: Final height and its predictive factors after renal transplantation in childhood. Pediatr Res 1994;36:323-328.
13. Fraser P, Hoch S, Erlandson D, Partridge R, Jackson J: The timing of menarche in juvenile rheumatoid arthritis. J Adolesc Health Care 1988;9:483-487.
14. van Diemen-Steenvoorde R, Donckerwolcke R: Growth and sexual maturation in paediatric patients treated by dialysis and following kidney transplantation. Acta Paediatr Scand 1988;343:109-116.
15. Schaeffer F, Veldhuis J, Stanhope R, Jones J, Schärer K, and the Cooperative Study Group on Pubertal Development in Chronic Renal Failure: Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. J Clin Endocrinol Metab 1994;78:1298-1306.
16. Ballinger A, Savage M, Sanderson I: Delayed puberty associated with inflammatory bowel disease. Pediatr Res 2003;53:205-210.
17. Feber J, Dupuis JM, Chapuis F, Braillon P, Jocteur-Monrozier D, Daudet G, So S, Levrey H, Hadj-Aîssa A, Martin X, Bellon G, Cochat P: Body composition and physical performance in children after renal transplantation. Nephron 1997;75:13-19.
18. Zak M, Hassager C, Lovell DJ, Nielsen S, Henderson CJ, Pedersen FK: Assessment of bone mineral density in adults with a history of juvenile chronic arthritis. Arthritis Rheum 1999;42:790-798.
19. van Staa TP, Cooper C, Leufkens HG, Bishop N: Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 2003;18:913-918.
20. Mehls O, Tönshoff B, Kovacs G, Mayer C, Schurek J, Oh J: Interaction between glucocorticoids and growth hormone. Acta Paediatr 1993;suppl 388:77-82.
21. Underwood LE: Growth retardation in chronic diseases: possible mechanisms. Acta Paediatr 1999;88(suppl 428):93-96.
22. Klaus G, Jux C, Fernandez P, Rodriguez J, Himmele R, Mehls O: Suppression of growth plate chondrocyte proliferation by corticosteroids. Pediatr Nephrol 2000;14:612-615.
23. Jux C, Leiber K, Hügel U, Blum W, Ohlsson C, Klaus G, Melhs O: Dexamethasone impairs growth hormone stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 1998;139:3296-3305.
24. Gafni R, Weise M, Robrecht D, Meyers J, Barnes K, De-Levi S, Baron J: Catch-up growth is associated with delayed senescence of the growth plate in rabbits. Pediatr Res 2001;50:618-623.
25. Mushtaq T, Farquharson C, Seawright E, Ahmed SF: Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line. J Endocrinol 2002;175:705-713.
26. Canalis E: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996;81:3441-3446.
27. Beaufrère B, Horber FF, Schwenk WF, Marsh HM, Matthews D, Gerich JE, Haymond MW: Glucocorticoids increase leucine oxidation and impair leucine balance in humans. Am J Physiol 1989;257:E712-E721.
28. Rebuffé-Scrive M, Krotkiewski M, Elferson J, Björntorp P: Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab 1988;67:1122-1128.
29. Stieger U, Lippuner K, Montandon A, Jeger P, Horber FF: Body composition and fuel metabolism after kidney grafting. Eur J Clin Invest 1995;25:809-816.
30. Lee DY, Park SK, Kim JS: Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children with nephrotic syndrome. J Clin Endocrinol Metab 1996;81:1856-1860.
31. Savage M, Beattie RM, Camacho-Hübner C, Walker-Smith JA, Sanderson IR: Growth in Crohn's disease. Acta Paediatr 1999;88(suppl 428):89-92.
32. De Benedetti F, Alonzi T , Moretta A , Lazzaro D, Costa P, Poli V, Martini A, Ciliberto G, Fattori E: Interleukin-6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99:643-650.
33. Garibotto G, Barreca A, Russo R, Sofia A, Araghi P, Cesarone A, Malaspina M, Fiorini F, Minuto F, Tizianello A: Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997;99:97-105.
34. Hardin D, Ellis KJ, Dyson M, Rice J, McConnell R, Seilhemer D: Growth hormone decreases protein catabolism in children with cystic fibrosis. J Clin Endocrinol Metab 2001;86:4424-4428.
35. Wilmore DW: The use of growth hormone in severely ill patients. Adv Surg 1999;33:261-274.
36. Horber FF, Haymond MW: Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990;86:265-272.
37. Bennet WM, Haymond MW: Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment. Clin Endocrinol 1992;36:161-164.
38. Ortoft G, Andreassen T, Oxlund H: Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia. J Bone Miner Res 1999;14:710-721.
39. Tönshoff B, Haffner D, Melhs O, Dietz M, Ruder H, Blum W, Heirich U, Stöver B and the Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts: Efficacy and safety of growth hormone treatment in short children with allografts: three years experience. Kidney Int 1993;44:199-207.
40. Hokken Koelega A, Stijnen T, de Ridder M, de Muinck Keizer-Shrama S, Wolff E, De Jong M, Donckerwolcke R, Groothoff JW, Blum W, Drop S: Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 1994:343:1313-1317.
41. Feber J, Cochat P, Lebl J, Krasnicanova H, Stepan J, David L, Braillon P, Bonnet L, Janda J: Body composition in children receiving recombinant human growth hormone after renal transplantation. Kidney Int 1998;54:951-955.
42. Mauras N, George D, Evans J, Milov D, Abrams S, Rini A, Welch S, Haymond MW: Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study. Metabolism 2002;51:127-135.
43. Touati G, Prieur AM, Ruiz JC, Noel M, Czernichow P: Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. Effects on growth velocity and body composition. J Clin Endocrinol Metab 1998;83:403-409.
44. Touati G, Ruiz JC, Porquet D, Kindermans C, Prieur AM, Czernichow P: Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy. J Rheumatol 2000;27:1287-1293.
45. Bechtold S, Ripperger P, Häfner R, Said E, Schwartz HP: Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study. J Pediatr 2003;143:512-519.
46. Simon D, Lucidarme N, Ruiz JC, Prieur AM, Czernichow P: Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy. J Rheumatol 2003;30:2492-2499.
47. Bechtold S, Ripperger P, Bonfig W, Schmidt H, Bitterling H, Häfner R, Schwartz HP: Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years. J Rheumatol 2004;31:1407-1412.
48. Bechtold S, Ripperger P, Bonfig W, Dalla Pozza R, Häfner R, Schwartz HP: Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 2005;90:3168-3173.
49. Davies UM, Rooney M, Preece MA, Ansell BM, Woo P: Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone. J Rheumatol 1994;21:153-158.
50. Davies UM, Jones J, Reeve J, Camacho-Hubner C, Charlett A, Ansell BM, Preece M, Woo P: Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin. Arthritis Rheum 1997;40:332-340.
51. Savino W, Postel-Vinay MC, Smamiotto S, Dardenne M: The thymus gland: a target organ for growth hormone. Scand J Immunol 2002;55:442-452.
52. Slonim A, Bulone L, Damore M, Goldberg T, Wingertzahn M, Mc Kinley M: A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 2000;342:1633-1637.
53. Fine, R, Stablein D, Cohen A, Tejani A, Kohaut E: Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 2002;62:688-696.
54. Guest G, Bérard E, Crosnier H, Chevallier T, Rappaport R, Broyer M: Effects of growth hormone in short children after renal transplantation. Pediatr Nephrol 1998;12:437-446.
55. Horber FF, Marsh M, Haymond MW: Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 1991;40:141-149.
56. Allen D, Julius J, Breen T, Attie K: Treatment of glucocorticoid-induced growth suppression with growth hormone. J Clin Endocrinol Metab 1998;83:2824-2829.
57. Van Es A: Growth hormone treatment in short children with chronic renal failure and after renal transplantation: Combined data from European clinical trials. The European Study Group. Acta Paediatr Scand Suppl 1991;379:42-48.